Data standards could unlock AI gains in clinical trials, extending benefits to LMICs
iskander · x · 2026-10-01
A clinical trial site monitor argues that trial data exists in two layers—source documentation and CRF entries in EDC systems—and that implementing data standards at trial sites would unlock safety and efficiency gains that AI can leverage. He highlights how a US-focused efficiency policy could also benefit trials in low- and middle-income countries, aligning with global health philanthropy goals.
More from Safety
- Multi-Turn Social Engineering Beats Support Agents: Why Single-Turn Tests Miss It — Significant_Camp4148 · 2026-10-01
- Frontier models safety-blocked on 85%+ of defensive cybersecurity benchmark tasks — ArtificialAnlys · 2026-10-01
- Researchers flag AI "delusional spiraling": sycophantic models amplify users' false beliefs — QuintinPope5 · 2026-10-01
- Senator Warns There Is No Kill Switch or Failsafe if AI Goes Wrong Fast — MariusHobbhahn · 2026-10-01
- California Bans Employers From Using AI to Monitor Workers' Brains and Emotions — bloomberglaw · 2026-10-01
- OpenAI's Greg Brockman Pulls Out of Second $25M Donation to AI Super PAC — pstAsiatech · 2026-10-01